Status:
RECRUITING
South East (Zuid Oost) Netherlands Heart Registry
Lead Sponsor:
Radboud University Medical Center
Collaborating Sponsors:
Maastricht Universitair Medisch Centrum
Zuyderland Medisch Centrum
Conditions:
Coronary Artery Disease
Acute Coronary Syndrome
Eligibility:
All Genders
Brief Summary
Rationale: Patients undergoing percutaneous coronary intervention (PCI) for chronic coronary syndrome (CCS) or acute coronary syndrome (ACS) have a residual risk of ischemic events after PCI due to th...
Detailed Description
Rationale: Patients undergoing percutaneous coronary intervention (PCI) for chronic coronary syndrome (CCS) or acute coronary syndrome (ACS) have a residual risk of ischemic events after PCI due to th...
Eligibility Criteria
Inclusion
- No in- or exclusion criteria are applied to gain 100% registration in order to prevent bias.
Exclusion
Key Trial Info
Start Date :
November 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2050
Estimated Enrollment :
99999 Patients enrolled
Trial Details
Trial ID
NCT06512493
Start Date
November 1 2020
End Date
January 1 2050
Last Update
July 25 2024
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
ZuyderlandMC
Heerlen, Limburg, Netherlands, 6419PC
2
MaastrichtUMC+
Maastricht, Limburg, Netherlands, 6229 HX
3
VieCuri
Venlo, Limburg, Netherlands, 5912 BL
4
Radboud University Medical Centre
Nijmegen, Netherlands